Roberto Vega

Dr. Roberto Vega

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
RVRoberto Vega
Roberto Vega
Gildardo Sanchez-AnteGildardo Sanchez-Ante
Gildardo Sanchez-Ante
LFLuis E. Falcon-Morales
Luis E. Falcon-Morales
Juan Humberto Sossa AzuelaJuan Humberto Sossa Azuela
Juan Humberto Sossa Azuela
EGElizabeth Guevara-Martínez
Elizabeth Guevara-Martínez

13 January 2022 in Forecasting
Verified
Journal Article
Open access
PDF file
RVRoberto Vega
Roberto Vega
JQJose Leonardo Leonardo Flores Quintanilla
Jose Leonardo Leonardo Flores Quintanilla
RGRussell Greiner
Russell Greiner
Accurate forecasts of the number of newly infected people during an epidemic are critical for making effective timely decisions. This paper addresses this challenge using the SIMLR model, which incorporates machine learning (ML) into the epidemiological SIR model. For each region, SIMLR tracks the changes in the policies implemented at the government level, which it uses to estimate the time-varying parameters of an SIR model for forecasting the number of new infections one to four weeks in advance. It also forecasts the probability of changes in those government policies at each of these future times, which is essential for the longer-range forecasts. We applied SIMLR to data from in Canada and the United States, and show that its mean average percentage error is as good as state-of-the-art forecasting models, with the added advantage of being an interpretable model. We expect that this approach will be useful not only for forecasting COVID-19 infections, but also in predicting the evolution of other infectious diseases.

1 October 2017 in The American Journal of Surgery
Verified
Journal Article
Closed access
DPDavid Pinzon
David Pinzon
RVRoberto Vega
Roberto Vega
YSYerly Paola Sanchez
Yerly Paola Sanchez
BZBin Zheng
Bin Zheng

1 November 2017 in JCO Clinical Cancer Informatics
Verified
Journal Article
Open access
FSFatemeh Seyednasrollah
Fatemeh Seyednasrollah
DKDevin C. Koestler
Devin C. Koestler
TWTao Wang
Tao Wang
SPStephen R. Piccolo
Stephen R. Piccolo
RVRoberto Vega
Roberto Vega
Pedro BallesterPedro Ballester
Pedro Ballester
Purpose: Docetaxel has a demonstrated survival benefit for patients with metastatic castration-resistant prostate cancer (mCRPC); however, 10% to 20% of patients discontinue docetaxel prematurely because of toxicity-induced adverse events, and the management of risk factors for toxicity remains a challenge.Patients and Methods: The comparator arms of four phase III clinical trials in first-line mCRPC were collected, annotated, and compiled, with a total of 2,070 patients. Early discontinuation was defined as treatment stoppage within 3 months as a result of adverse treatment effects; 10% of patients discontinued treatment. We designed an open-data, crowd-sourced DREAM Challenge for developing models with which to predict early discontinuation of docetaxel treatment. Clinical features for all four trials and outcomes for three of the four trials were made publicly available, with the outcomes of the fourth trial held back for unbiased model evaluation. Challenge participants from around the world trained models and submitted their predictions. Area under the precision-recall curve was the primary metric used for performance assessment.Results: In total, 34 separate teams submitted predictions. Seven models with statistically similar area under precision-recall curves (Bayes factor ≤ 3) outperformed all other models. A postchallenge analysis of risk prediction using these seven models revealed three patient subgroups: high risk, low risk, or discordant risk. Early discontinuation events were two times higher in the high-risk subgroup compared with the low-risk subgroup. Simulation studies demonstrated that use of patient discontinuation prediction models could reduce patient enrollment in clinical trials without the loss of statistical power.Conclusion: This work represents a successful collaboration between 34 international teams that leveraged open clinical trial data. Our results demonstrate that routinely collected clinical features can be used to identify patients with mCRPC who are likely to discontinue treatment because of adverse events and establishes a robust benchmark with implications for clinical trial design.

2 November 2017 in Neuroscience Bulletin
Verified
Journal Article
Closed access
SLSugai Liang
Sugai Liang
RVRoberto Vega
Roberto Vega
XKXiangzhen Kong
Xiangzhen Kong
WDWei Deng
Wei Deng
QWQiang Wang
Qiang Wang
TLTao Li
Tao Li

19 July 2016 in Artificial Intelligence Research
Verified
Journal Article
Open access
PDF file
RVRoberto Vega
Roberto Vega
TSTouqir Sajed
Touqir Sajed
KMKory Wallace Mathewson
Kory Wallace Mathewson
KKKriti Khare
Kriti Khare
PPPatrick M. Pilarski
Patrick M. Pilarski
JAJavier M. Antelis
Javier M. Antelis
Recognition of motor imagery tasks (MI) from electroencephalographic (EEG) signals is crucial for developing rehabilitation andmotor assisted devices based on brain-computer interfaces (BCI). Here we consider the challenge of learning a classifier, basedon relevant patterns of the EEG signals; this learning step typically involves both feature selection, as well as a base learningalgorithm. However, in many cases it is not clear what combination of these methods will yield the best classifier. This papercontributes a detailed assessment of feature selection techniques, viz., squared Pearson’s correlation (R2), principal componentanalysis (PCA), kernel principal component analysis (kPCA) and fast correlation-based filter (FCBF); and the learning algorithms:linear discriminant analysis (LDA), support vector machines (SVM), and Feed Forward Neural Network (NN). A systematicevaluation of the combinations of these methods was performed in three two-class classification scenarios: rest vs. movement,upper vs. lower limb movement and right vs. left hand movement. FCBF in combination with SVM achieved the best results witha classification accuracy of 81.45%, 77.23% and 68.71% in the three scenarios, respectively. Importantly, FCBF determines, basedon the feature set, whether a classifier can be learned, and if so, automatically identifies the subset of relevant and non-correlatedfeatures. This suggests that FCBF is a powerful method for BCI systems based on MI. Knowledge gained here about proceduralcombinations has the potential to produce useful BCI tool, that can provide effective motor control for the users.